Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
15m
FDA greenlights Regeneron’s Dupixent for the treatment of COPD
With an approval based on two pivotal Phase III studies, Dupixent is now the first-ever biologic indicated for treating COPD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Promotes watch collection
Pleads not guilty
'Harry Potter' star dies
Stadiums to serve as shelters
World's oldest cheese found
Targeted Black residents?
Killer gets life sentence
50/50 ball ownership suit
Producing doc on Diddy
Ending password-sharing
Boxes to distribute Narcan
Urgent safety alert for 737s
On Secret Service failures
Chinese submarine sank
NC board removes 747K
WI duplicate ballot flap
Fake Biden robocalls fine
Heads to US-Mexico border
NIH finds misconduct
More executives leave
ISR targets Hezbollah HQ
Capital goods orders up
US charges three Iranians
Military recruiting rebounds
Related topics
Sanofi
Regeneron
Food and Drug Administration
Chronic obstructive pulmonary disease
Feedback